Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
2
×
life sciences
national blog main
akcea therapeutics
amgen
anylam pharmaceuticals
biotech
boston blog main
boston top stories
calcitonin gene-related peptide
cardiomyopathy
chronic migraine
eli lilly
episodic migraine
fda
indiana
indiana blog main
indiana top stories
inotersen
migraine
national top stories
neuropathy
new york
new york blog main
new york top stories
onpattro
patisiran
pfizer
san diego blog main
san diego top stories
tafamidis
tegsedi
teva pharmaceutical
the institute for clinical and economic review
transthyretin amyloidosis
What
approved
2
×
drug
fda
medicines
2
×
ago
akcea
alnylam
amyloidosis
announced
approval
attr
available
battle
class
debilitating
decision
developed
disease
eli
genetic
headache
late
lilly
marks
migraine
new
oks
pain
patients
pfizer
prevent
rare
sets
starts
thursday
transthyretin
won
year
Language
Current search:
medicines
×
approved
×
drugs
×
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
